Thrombofilias and the Risk of Recurring Pregnancy Loss in a Mexican Population
Journal Title: Medical Journal of Clinical Trials & Case Studies - Year 2020, Vol 4, Issue 5
Abstract
Background: Recurrent gestational loss (RPL) is defined by the ESHRE as the loss of 2 or more consecutive pregnancies. The objective of this study is to evaluate the relationship of Factor V Leiden (FVL, G1691A), prothrombin G20210A (PRT, G20210A), methylenetetrahydrofolate reductase G677A (MTHFR C677AT) and plasminogen activator inhibitor-1 (4G / 5G) (PAI-1, 4G / 5G); with recurrent gestational loss and perinatal data of Mexican women. Material and Method: Retrospective, observational and cross-sectional study, which includes 277 pregnancies of 95 women and three groups were formed: 1) Control: deliveries of patients without pregnancy loss, without problems during the development of pregnancy and with a study of hereditary thrombophilias, 2) idiopathic fetal death: Deliveries of patients with idiopathic gestational loss (= 1) and with study of thrombophilias, and 3) recurrent pregnancy loss. Deliveries of patients with idiopathic recurrent pregnancy loss and with study of hereditary thrombophilias; patient data was collected; age, weight and height, newborn data, weeks of gestation, weight and height, which are reported with mean ± standard error and analyzed with the student's t test, and thrombophilias, cesarean sections, deliveries and spontaneous abortions are reported in percentages and analyzed with chi2, in both cases the SPSS version 25 statistical package was used. Results: Of the 95 women included there were no significant differences in age, weight and height in the different rates of each group; one of the thrombophilias to be evaluated in the different populations, it was observed that FVL-G1691A only occurs in recurrent pregnancy loss (15.4%). The translation of homozygous and heterozygous, it was observed that FVL-G1691A only appeared in recurrent pregnancy loss, perinatal data showed a decrease in the weeks of gestation in newborns of mothers with recurrent pregnancy loss, with a decrease in weight and size. Conclusions: the presence of inherited maternal thrombophilias increases the risk of recurrent pregnancy loss, premature birth, and decreased weight and height at birth.
Authors and Affiliations
Estuardo LIJ , Carlos DM , Alejandro KB , Roberto HR , Felipe de Jesús AP , Juan GVJ , Daniela AR , Maruxa PF , Angélica PNM and Manuel VHV
Keywords
Related Articles
- EP ID EP756214
- DOI 10.23880/mjccs-16000269
- Views 6
- Downloads 0
Morphological and Essential Oils Diversities among Twelve Tunisian Mentha spp. Accessions
Eight quantitative and thirteen qualitative traits were analyzed using univariate and multivariate analysis. Significant differences have been showed between the accessions and the cluster analysis revealed five main gr...
Mucoepidermoid Carcinoma of the Thyroid Gland with Lymphovascular Invasion A Case Report
Mucoepidermoid carcinomas (MECs) are generally found in salivary glands, but they have also been mentioned in other organs such as the larynx, esophagus, and breast. Mucoepidermoid carcinoma (MEC) of the thyroid is a ver...
Reporting Quality Assessment of COVID-19 Clinical Trials in China at the beginning of the Pandemic: An Empirical Study based on the CONSORT Statement
Objectives: This study aimed to evaluate the reporting quality and risk of bias of Chinese COVID-19 RCTs. Methods: The Chinese clinical trial registry (ChiCTR) was searched for registered COVID-19 clinical trials before...
Frequency of Anencephaly in All Pregnant Population: An Observational Study
The present study was conducted in the Department of Obstetrics and Gynaecology of Federal Government Services Hospital Islamabad, Pakistan, for a six months period, in order to calculate frequency of anencephaly and ide...
Ventricular Arrhythmia Complicating Treatment with Hydroxychloroquine and Azithromycin in a Covid-19 Patient
Oseltamivir (Tamiflu), a neuraminidase inhibitor, an antiviral medication. Although of its effectiveness, still the fear of Tamiflu resistance is concerning. Tamiflu is available in limited pharmacies with an expensive...